The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/38325
StudyName: Eligibility Breast Neoplasms NCT01605396
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 10.10.2019
License: Creative Commons BY 4.0

----

Description: 
A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064); ODM derived from: https://clinicaltrials.gov/show/NCT01605396
